These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23152028)

  • 1. [A case of recurrent gastrointestinal stromal tumor with complete response from treatment with reduced dose of imatinib mesylate].
    Toyokawa T; Yamashita Y; Yamamoto A; Shimizu S; Inoue T; Ikehara T; Sakashita K; Kanehara I; Teraoka H; Nishiguchi Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1723-5. PubMed ID: 23152028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of recurrent gastrointestinal stromal tumor of the stomach with complete response to imatinib mesilate].
    Aoyama T; Saeki H; Samejima J; Fujii K; Ishikawa Y; Kawamoto M; Fujisawa J; Matsukawa H; Rino Y; Masuda M
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):975-8. PubMed ID: 19542718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two cases of recurrent GIST successfully treated with imatinib mesylate at 100mg/day].
    Hanada N; Kawata K; Okamura S; Tomiyama N; Hori K
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):803-5. PubMed ID: 23863663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of gastric gastrointestinal stromal tumor operated after low-dose chemotherapy with imatinib mesylate].
    Hori K; Hanada N; Kusano S; Tsurumoto Y; Sakashita N; Uchino R
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1749-51. PubMed ID: 18931581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peritoneal dissemination from gastrointestinal stromal tumor of small intestine responding completely to imatinib mesylate (STI 571)].
    Yamanaka H; Mizushima T; Mikata S; Ito T; Nonaka K; Ide H; Michiura T; Kainuma S; Iwase K
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2125-8. PubMed ID: 16352942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of Giant GIST of the stomach successfully treated with imatinib mesylate neoadjuvant therapy and followed postoperatively].
    Okuda H; Tanaka H; Ueno M; Shitani M; Nasuno M; Suzuki C; Nishimura S; Kimura H; Yonezawa K; Abe T; Yoshida Y; Kawabata M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1941-4. PubMed ID: 16282731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term survival in a case of recurrent gastrointestinal stromal tumor treated with intermittent or low-dose imatinib].
    Kurata Y; Takaishi S; Sakuma Y; Iwasaki K; Nimura Y; Tohma T; Kagaya A; Yamamoto Y; Matsubara H
    Gan To Kagaku Ryoho; 2014 Mar; 41(3):379-82. PubMed ID: 24743288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of extragastric pedunculated gastrointestinal stromal tumor of the stomach with peritoneal dissemination].
    Kikuchi A; Liu B; Chikatani K; Nishida K; Kawashima H; Miyamoto H; Kakimoto M; Goto H; Yoshimura T; Koshiishi H; Okamura T
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2387-9. PubMed ID: 23268086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatic metastasis from gastric GIST radically resected after imatinib mesylate therapy-a case report].
    Kittaka H; Yamada T; Goto K; Ogawa H; Shingai T; Motoori M; Takahashi H; Kishi K; Noura S; Miyashiro I; Ohue M; Ohigashi H; Yano M; Ishikawa O
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2508-10. PubMed ID: 22202429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of complete response after imatinib mesylate treatment of advanced GIST.
    Papaxoinis G; Nikolaou M; Lianos E; Gaglia A; Economopoulos T; Pectasides D
    Anticancer Res; 2006; 26(6C):4869-72. PubMed ID: 17214353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A gastric stromal tumor (GIST) with a prolonged partial response to a reduced dose of imatinib mesilate].
    Nakatani K; Tanabe S; Nishimura K; Shimoda T; Azuma M; Katada C; Sasaki T; Higuchi K; Koizumi W; Saigenji K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):997-1000. PubMed ID: 16835496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of an elderly patient with recurrent GIST, which was effectively treated with low-dose imatinib mesylate].
    Matsumoto S; Takahashi M; Ishizu H; Takahashi H; Masuko H; Tanaka K; Hata T; Yamagami H; Takahashi S; Tahara M; Ueki S; Kuji M; Tanioka T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2405-7. PubMed ID: 25731538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent GI bleeding and surgery following the initial response to imatinib therapy in GIST of the stomach.
    El Hajj II; Chehal A; El Saghir NS
    Dig Dis Sci; 2005 Jan; 50(1):65-9. PubMed ID: 15712639
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathological complete response in a large gastric GIST that became resectable after neoadjuvant chemotherapy with imatinib mesylate].
    Otsubo D; Sawa H; Fukuoka E; Murata K; Mii Y; Oka S; Iwatani Y; Kuroda D
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2402-4. PubMed ID: 25731537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case report of two-term surgery for focal progression of a huge liver metastasis and peritoneal dissemination from gastrointestinal stromal tumor during imatinib mesylate treatment].
    Toyokawa T; Teraoka H; Kitayama K; Nomura S; Kanehara I; Nishino H
    Gan To Kagaku Ryoho; 2014 Mar; 41(3):373-7. PubMed ID: 24743287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of recurrent intestinal GIST with long-term survival-beneficial effect of multimodality therapy using high-dose imatinib and surgery].
    Akasaka H; Koyama M; Yokoyama H; Morohashi H; Sakamoto Y; Murata A; Hakamada K
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1975-7. PubMed ID: 23267948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experience of imatinib mesylate for metastatic or recurrent gastrointestinal stromal tumor].
    Toyokawa T; Yamashita Y; Yamamoto A; Shimizu S; Inoue T; Kanazawa A; Tsukamoto T; Ikehara T; Nishiguchi Y
    Gan To Kagaku Ryoho; 2014 Jan; 41(1):55-8. PubMed ID: 24423952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate.
    Rutkowski P; Nowecki Z; Nyckowski P; Dziewirski W; Grzesiakowska U; Nasierowska-Guttmejer A; Krawczyk M; Ruka W
    J Surg Oncol; 2006 Mar; 93(4):304-11. PubMed ID: 16496358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of small intestinal GIST maintained as a long stable disease by imatinib mesylate 400 mg/day, alternate-day administration for 2 weeks followed by a 2 week interval].
    Nakamura T; Shiraishi S; Kitamura N; Taniguchi M; Okauchi H; Shimomatsuya T; Maruhashi K
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1695-8. PubMed ID: 21996970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case.
    Ando Y; Tsunoda T; Beck Y; Takayama T; Tahara H
    Surg Today; 2005; 35(2):157-60. PubMed ID: 15674500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.